Category Earnings Results

CRISIL Ltd
CRISIL Q3 Results: Net Profit Rises 7% to ₹225 Crore, Revenue Flat – Full Analysis

CRISIL Ltd: Business and Industry Overview 

CRISIL Ltd started in 1987, with collaboration between ICICI (Industrial Credit and Investment Corporation of India) and UTI (Unit Trust of India). CRISIL was the first credit rating agency in India. The operational segments of CRISIL are Research, Benchmarking, Consulting services and Analytics. It has expanded its footprint in multiple countries around the globe in USA, Europe, Middle East, Australia, and countries of Asia, serving many international big clients. CRISIL was later demerged from ICICI and was acquired by a US company S&P Global Ltd a credit scoring company. It has established really strong brands under its umbrella to expand in many service segments to become Ace. It started CRISIL Ratings, CRISIL Intelligence for market intelligence and analytics business segment, CRISIL Integral IQ and many more. It has total of 4600+ employees working over 12 countries. As this year’s government budget is more favoured towards consumption side, which will increase the money circulation in economy and will eventually result in higher inflation. CRISIL expects India’s GDP growth to be 6.5% for next fiscal year. It thinks bond issuances may experience tailwinds driven by easing in monetary policies. The industrial lending segment in short future will stay range bound but the personal lending portfolio of banks might see an increase.  

Latest Stock News 

Investors prefer the high quality of CRISL’s rating which has given CRISIL Ratings services a leading position in corporate bond segment. Research, Analytics and Solutions saw demand in buy-side offerings, consulting, and credit and risk offerings from global clients. In Q4 FY23, company saw gain of ₹29.4 crore due to sharp devaluation of Argentinian peso, and if we exclude that then PBT grew by 18.1% in this quarter YoY. Final dividend of ₹26 per share was declared, making the total dividend of ₹56 per share this year compared to ₹54 in FY23. It has recognized as a category leader in Chartis’ RiskTechCredit Portfolio Management (CPM) Solutions 2024 Quadrant, receiving 15 recognitions. To engage with clients it hosted 9th annual NBFC seminar in Mumbai, hosted conclave in real estate segment with title of ‘Shaping the Future of Real Estate’. CRISIL Coalition Greenwich hosted competitive challenges for asset managers in Chicago. CRISIL Integral IQ sponsored risk finance events focusing on trends in model risk, investment risk, impact of AI and technology, etc. During this quarter, CRISIL Foundation expanded its outreach and provided help to more than 4 lakh rural community members in Assam and Rajasthan under its flagship program ‘Mein Pragati’. 

Segment Information 

  • Ratings Services: This subsidiary provides ratings, which can help the issuers for funding and also for borrowers. Its services give an internal evaluation processes which includes screening of companies to ensure their operations and capabilities to repay or provide funding. Its services are majorly use in calculating the capital adequacy of banks. It has given rating to over 7000+ large and medium corporates and financial institutions. 
  • Research, Analytics and Solutions: It helps its clients with making strategic decisions, as it is expertise in collecting data and providing solutions to make companies grow their business and revenues. It has also worked with Indian Government as a support in making of PPP framework for India. Its services are offered in Asia, Africa and Middle East countries. It is the official rating provider of Indian Mutual Funds and a largest provider for fixed income valuations in India, covering more than ₹197 trillion. It also launched India’s first AIF benchmark to help AIF portfolios to compare their performance. 
  • International Business: It is a leading strategy implementation partner that works across globe helping companies in mitigating risks, make better decision, productive environment and enhance their returns. It serves 15 leading global investment bankers, 5 leading insurers, 40 credit risk teams of global banks.  

Subsidiaries Information 

  • CRISIL ESG Ratings & Analytics Ltd: This subsidiary provides ratings to companies and to banks globally for its credit lending or funding services helping them to optimize their capital. CRISIL ESG Ratings is registered with SEBI as a ‘Category 1’ ESG rating provider (ERP). It serves major banks, institutional and retail investors, asset managers, Mutual Funds and asset managers. 
  • Bridge to India Energy Private Limited: It is the leading consultancy and knowledge services provider in Indian renewable energy market. It provides wide range of services of consulting and research to contractors, companies, banks, government agencies, developers, financial institutions, etc. It is taking benefit of the comprehensive database it has to provide research and help their clients to grow and make the industry better. 
  • CRISIL Irevna Information Technology Columbia S.A.S: This subsidiary is based in Columbia, where many financial and technological professors work. It takes the outsourcing work of some key North American clients and helps them by providing research and strategic decision to grow their business. CRISIL has commenced a new unit in Columbia in Bogota to help them offer more services to their international clients. 
  • CRISIL Ratings Ltd: This subsidiary provides rating services to banks, financial institutions, mutual funds to rate their debt funding which will enhance the information making easy to invest or lend. Issuers and borrowers leverage its ratings to access funding, widening range of funding alternatives and optimize their capital. Government has made it compulsory for each mutual fund to have ratings, so that investors can make informed investments. 

Q3 FY25 Earnings 

  • Revenue of ₹913crore in Q3 FY25 down by 0.43% YoY from ₹917 crore in Q3 FY24.  
  • EBITDA of ₹317.7 crore in this quarter at a margin of 34.8% compared to 38.1% in Q3 FY24. 
  • Profit of ₹224.7 crore in this quarter compared to a ₹210 crore profit in Q3 FY24. 

Financial Summary 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 913 917 3139 3259 
Expenses 648.7 672.1 2365.5 2423 
EBITDA 317.7 349.4 975.1 1000 
OPM 34.8% 38.1% 31% 30.7% 
Other Income 30.2 33.2 93.6 89.6 
Net Profit 224.7 210.2 658 684 
NPM 24.6% 22.9% 20.9% 20.9% 
EPS 30.72 28.74 90.1 93.55 
GSK Pharma Ltd
GlaxoSmithKline Pharma Q3 Results: Strong Net Profit Soars 400% to ₹228.58 Cr, Revenue Up 18% YoY

Business and Industry Overview: 

GlaxoSmithKline Pharmaceuticals Limited (GSK Pharmaceuticals) is a leading research-based pharmaceutical and healthcare company in India, functioning as a subsidiary of the global entity GSK plc. Founded on November 13, 1924, originally as H.J. Foster & Co. Limited, the company has transformed over the decades into a significant player in India’s pharmaceutical sector. GSK is recognized as one of the top 10 drug manufacturers worldwide. In India, GSK’s operations include General Medicines, Pediatric Vaccines, and Adult Vaccines. The company’s Respiratory portfolio features products like Nucala and Trelegy, while its Adult Immunization category includes the Shingrix Herpes Zoster Vaccine. GSK is also implementing an omnichannel strategy to enhance its reach and service coverage. As of 2024, GSK’s net asset value was approximately 128 million Indian rupees. The company’s future performance may fluctuate due to various factors, including changes in industry trends, market conditions, government regulations, and other unforeseen circumstances. 

India is the largest global supplier of generic drugs and is well-known for its affordable vaccines and generic medications. The Indian pharmaceutical industry is currently ranked third in the world in terms of pharmaceutical production by volume. Over the past nine years, this sector has flourished, with a compound annual growth rate (CAGR) of 9.43%.  Key segments within the Indian pharmaceutical industry include generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research and manufacturing, biosimilars, and biologics. India has the highest number of pharmaceutical manufacturing facilities that comply with the standards set by the U.S. Food and Drug Administration (USFDA). The country is home to numerous producers, which account for approximately 8% of the global active pharmaceutical ingredient (API) market. GSK is the leading player in this market, boasting a market share of 33%. 

Latest Stock News: 

GlaxoSmithKline (GSK) Pharmaceuticals announced an impressive 402% year-on-year (YoY) increase in consolidated net profit for the December quarter (Q3 FY25), reaching ₹228.58 crore, up from ₹45.49 crore in the same period last year. On February 14, GSK Pharmaceuticals reported an 18% revenue increase to ₹946 crore for the quarter ending December 31, 2024, along with a profit after tax of ₹229 crore. 

During this quarter, the company’s revenue from operations rose to ₹946.36 crore, reflecting a 17.5% YoY increase from ₹804.98 crore in Q3 FY24.  

However, compared to the previous quarter, the company experienced a decline: net profit fell by 8.08%, and revenue decreased by 5.4%, down from ₹248.68 crore and ₹1,000.05 crore reported in Q2 FY25, respectively. 

Segmental information:

Pharmaceuticals: GSK Pharmaceuticals offers a diverse range of prescription medicines across various therapeutic areas, including anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular diseases, and respiratory ailments. 

Key Products: The company’s portfolio features leading brands such as Augmentin, a widely used antibiotic, and respiratory therapies like Nucala and Trelegy. These products have significantly contributed to the company’s growth, with Augmentin maintaining its position as the No.1 brand in the Indian pharmaceutical market.  

Pediatric Vaccines: GSK Pharmaceuticals provides vaccines aimed at preventing diseases such as hepatitis A and B, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, and cervical cancer. The pediatric vaccine portfolio has demonstrated double-digit growth, maintaining market leadership in the private sector. 

Adult Vaccines: The company is advancing adult immunization in India, notably with Shingrix, a vaccine for shingles. Innovative marketing strategies, including awareness campaigns featuring prominent figures, have bolstered the uptake of adult vaccines.  

Subsidiary Information:

ViiV Healthcare: Specializing in HIV treatment and prevention, ViiV Healthcare is a joint venture where GSK plc holds a majority stake of 76.5%, while Pfizer and Shionogi own 13.5% and 10%, respectively. This collaboration focuses on delivering advanced HIV therapies worldwide. 

Stiefel Laboratories: Acquired by GSK in 2009, Stiefel Laboratories specializes in dermatology products, thereby enhancing GSK’s portfolio in skin-related treatments. 

Reliant Pharmaceuticals: Purchased by GSK in 2007, Reliant Pharmaceuticals contributed a range of cardiovascular products, including Lovaza, an omega-3-acid ethyl ester, to GSK’s portfolio. 

Haleon: In July 2022, GSK plc demerged its consumer healthcare business to form Haleon, which focuses on over-the-counter products and wellness. This strategic move allowed GSK to concentrate more on its biopharmaceutical segments. 

Q3 Highlights:

  • GSK Pharmaceuticals reported a 402% YoY increase in net profit for Q3 FY25, totaling ₹228.58 crore (up from ₹45.49 crore last year).  
  • Revenue for the December 2024 quarter rose 18% to ₹946 crore. Revenue from operations increased by 17.5% YoY to ₹946.36 crore, compared to ₹804.98 crore in Q3 FY24.  
  • Compared to Q2 FY25, net profit fell by 8.08% and revenue decreased by 5.4% (down from ₹248.68 crore and ₹1,000.05 crore, respectively). 

Financial Summary:

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 805.00 949.00 3,252 3,454 
Expenses 587 658 2,447 2,545 
EBITDA 218 292 804.00 909.00 
OPM 27% 31% 25% 26% 
Other Income -135 35 103 -21 
Net Profit 46.00 230.00 611 590 
NPM 5.71 24.24 18.79 17.08 
EPS 2.7 13.57 36.05 34.83 
Rail Vikas Nigam Ltd
Rail Vikas Nigam Ltd Q3 Results: Profit Down 13%, Revenue Slips 3%

Business and Industry Overview: 

Rail Vikas Nigam Limited (RVNL), a Central Public Sector Enterprise has been given the status of a Navratna PSU in India. It was established in 2003 under the Ministry of Railways. The organization aims to execute project development, financing, and implementation for all types of railway infrastructure. The primary focus of RVNL is to implement transportation infrastructure projects related to Indian Railways while mobilizing extra-budgetary resources through Special Purpose Vehicles (SPVs). Over its two decades of operation, RVNL has completed more than 150 railway projects. It has also expanded its focus to a broader range of infrastructure projects, both domestically and internationally. RVNL arranges financial resources, undertakes project execution, creates project-specific SPVs, and commercializes projects. After RVNL completes a railway project, the respective Zonal Railway operates and maintains it under specific financial arrangements. In the fiscal year 2021-22, RVNL successfully completed 18 projects, with a total of 102 projects completed since its inception up to March 2021. Currently, there are 72 projects at various stages of implementation by RVNL. The company is publicly traded on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). 

As of March 31, 2023, the Indian railway network covers a route length of 68,584 kilometers (42,616 miles). The track sections are rated for speeds ranging from 80 to 200 kilometers per hour (50 to 124 miles per hour), with the maximum speed achieved by passenger trains being 160 kilometers per hour (99 miles per hour). Indian Railways, one of the largest railway networks managed under a single entity, transported approximately 19.8 million passengers and 2.4 million tonnes of freight each day in 2009, making it one of the world’s largest employers. The railways play a crucial role in transporting passengers and cargo across India’s vast territory, and RVNL is the only authority responsible for building and maintaining railway infrastructure. 

Latest Stock News: 

 On February 14, 2025, Rail Vikas Nigam’s stock price decreased by 2.19%, closing at ₹378.95 per share. The stock is currently trading at ₹370.65 per share. During the day, the stock reached a high of ₹387.40 and a low of ₹365.90. The company has a market capitalization of ₹78,992.43 crore, with a 52-week high of ₹647 and a low of ₹213. The BSE recorded a trading volume of 609,577 shares. 

RVNL on Friday (February 14) reported a 13.1% year-on-year (YoY) dip in net profit at ₹311.6 crore for the third quarter that ended December 31, 2024. In the same period in FY24, the company saw a net profit of ₹358.6 crore. 

At the operating level, EBITDA (earnings before interest, tax, depreciation, and amortisation) was down 3.9% YoY to ₹239.4 crore in Q3FY25 over ₹249 crore. The EBITDA margin was largely flat at 5.2% compared to 5.3% in the corresponding period in the previous fiscal. 

Segmental Information: 

New Lines/Doubling: The company has completed 1,343 km of project length, which includes 119 km of New Line, 925 km of Doubling, and 299 km of Railway Electrification, all of which have been handed over to the Zonal Railway. Additionally, it completed 863 km of the Metropolitan Transport Project. 

Railway Electrification: The company commissioned 299 route km (681 track km) of pure Railway Electrification works. 

Metro: RVNL commissioned the Joka-Taratala (13 km) section of Kolkata Metro and the New Garia-Hemanta Mukherjee (11 km) section of the New Garia-Biman Bandar Section. 

Subsidiary Information: 

High Speed Rail Corporation of India Limited: The High Speed Rail Corporation of India Limited (HSRC) is an SPV incorporated in 2012 as a subsidiary of RVNL to implement high-speed rail projects in India. 

Kinet Railway Solutions Ltd: RVNL has established a private company, Kinet Railway Solutions Ltd, which will act as the SPV signing the manufacturing-cum-maintenance agreement with the Ministry of Railways. 

Kyrgyzindustry-RVNL: RVNL also formed a 50:50 joint venture with the Kyrgyz company Kyrgyz Industry. This joint venture will develop rail, road, and other infrastructure in Kyrgyzstan.  

Q3 Highlights: 

  • Revenue went down to ₹4591 in Q3 FY25 from ₹4676 in the last quarter Q3 FY24.  
  • EBITDA was down 3.9% YoY to ₹239.4 crore in Q3FY25 over ₹249 crore.  
  • Shares of Rail Vikas Nigam Ltd ended at ₹360, down by ₹18.95, or 5%, on the BSE. 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 4,676.00 4,591.00 20,282 21,733 
Expenses 4,676 4,328 20,282 21,733 
EBITDA 246 263 1,244.00 1,346.00 
OPM 5% 6% 6% 6% 
Other Income 326 284 1,004 1,183 
Net Profit 326.00 295.00 1,268 1,463 
NPM 6.97 6.43 6.25 6.73 
EPS 1.56 1.41 6.08 7.02 
Samvardhana Motherson
Samvardhana Motherson Q3 Results: 55.4% YoY Profit Surge to ₹984.35 Cr and Overview

Business and Industry Overview: 

Samvardhana Motherson is India’s leading auto parts manufacturer in terms of market capitalization, with notable clients including Maruti Suzuki and Mercedes-Benz. The company, officially known as Samvardhana Motherson International Ltd (formerly Motherson Sumi Systems Ltd), is a multinational manufacturer of automotive components headquartered in Noida, India. It specializes in producing wiring harnesses, plastic components, and rearview mirrors for passenger cars. Established in 1986, the company began as a joint venture with the Sumitomo Group of Japan. The Motherson Group provides a wide range of products and services through its 12 business divisions. With the support of its customers, these divisions continue to strengthen and diversify, helping Motherson move closer to its vision of becoming a globally preferred provider of sustainable solutions. The three key divisions of the group—Wiring Harness, Vision Systems and Modules, and Polymer Products—account for over 95% of the group’s revenues. Operating in 41 countries across North America, South America, Europe, South Africa, the Middle East, Asia-Pacific, and Australia, SAMIL manages more than 270 manufacturing facilities and employs over 135,000 professionals worldwide. This extensive global presence allows the company to effectively serve major automotive manufacturers, including Maruti Suzuki, Mercedes-Benz, Tata Motors, Volkswagen, Ford Motor Company, and Porsche. 

India’s auto parts industry is experiencing significant growth, with a projected value of $200 billion by 2026. This growth is driven by strong demand from both international markets and the local aftermarket, as well as original equipment sectors. In 2024, India produced 100,000 electric cars and 900,000 electric two-wheelers. However, Internal Combustion Engine (ICE) vehicles continue to dominate the market, with 20 million two-wheelers and 5 million cars still in circulation. The auto component industry plays a crucial role in India’s economy, contributing 2.3% to the GDP and employing over 1.5 million people. It is projected to grow to 5-7% of the GDP by 2026, which could create an additional 3.2 million jobs. Additionally, the industry is a leader in exports, with an estimated export value of $21.2 billion for 2023-24. Significant markets for these exports include North America, Europe, and Asia, with North America alone accounting for 32% of total exports and experiencing a 5% growth rate. Samvardhana Motherson India has a market share of more than 40% in the Indian wiring harness industry. 

Latest Stock News: 

Indian auto parts manufacturer Samvardhana Motherson reported a smaller-than-expected increase in its third-quarter profit on Friday, impacted by weak global car sales. For the quarter ending December 31, the company’s consolidated profit rose to Rs 8.79 billion ($101 million). However, this figure fell short of analysts’ estimates, which predicted a profit of Rs 9.4 billion, according to data compiled by LSEG. Quarterly revenue increased 8 percent.  

Segmental information: 

Wiring Harnesses: One of the major segments is Wiring Harnesses, which serve as the electrical distribution system for vehicles. These harnesses consist of a network of cables, connectors, and terminals that transmit power and signals between different electronic components. They are essential for various vehicle functions, including lighting, infotainment, engine control, and battery management in electric vehicles (EVs). 

Rearview Mirrors: Another important segment is Rearview Mirrors, which includes both exterior and interior mirrors equipped with advanced features. Modern rearview mirrors incorporate technologies such as electrochromic dimming (anti-glare), blind-spot detection, integrated cameras, and turn indicators. Samvardhana Motherson Reflectec (SMR), a subsidiary of SAMIL, is a global leader in automotive mirror systems. 

Moulded Plastic Parts: The Moulded Plastic Parts segment focuses on interior and exterior vehicle components made from plastic. These include dashboards, door trims, bumpers, center consoles, and air vents. Lightweight plastic components help improve fuel efficiency and reduce vehicle weight, which is especially important for EVs and modern fuel-efficient cars. SAMIL’s subsidiary, Samvardhana Motherson Peguform (SMP), specializes in these components, catering to global automakers. 

Rubber Components: The Rubber Components segment covers products such as seals, gaskets, and weatherstrips, which play a crucial role in noise reduction, vibration damping, and sealing gaps in vehicles. These components help prevent water leakage, reduce wind noise, and maintain cabin insulation, contributing to passenger comfort and vehicle durability. 

Modules and Systems: The Modules and Systems segment offers integrated solutions, including cockpit modules, complete door panels, instrument panels, and lighting systems. These pre-assembled units simplify installation for automakers and enhance production efficiency. The company’s expertise in module assembly and system integration makes it a valuable partner for major global auto manufacturers. 

Subsidiary Information:   

1. Samvardhana Motherson Reflectec (SMR : SMR is a leading global supplier specializing in rearview mirrors and camera-based detection systems. The subsidiary focuses on manufacturing exterior and interior mirrors equipped with advanced technologies, such as auto-dimming, integrated cameras, blind-spot detection, and turn indicators. These smart mirror solutions enhance driver safety and visibility, making them a critical component in modern vehicles. SMR serves major automakers worldwide, contributing significantly to SAMIL’s global revenues. 

2. Samvardhana Motherson Peguform (SMP) : SMP specializes in interior and exterior polymer modules, producing components such as dashboards, door panels, bumpers, and center consoles. These parts are essential for vehicle aesthetics, functionality, and structural integrity. SMP’s expertise in lightweight plastic components helps automakers improve fuel efficiency and reduce vehicle weight, aligning with the growing demand for electric and fuel-efficient vehicles. Through SMP, SAMIL has strengthened its position as a key supplier of high-quality plastic modules in the global automotive market. 

3. PKC Group : PKC Group is a Finnish company acquired by SAMIL in 2017, enhancing its expertise in wiring harnesses for commercial vehicles. Wiring harnesses are critical for electrical power distribution and signal transmission in automobiles, and PKC Group’s specialization extends beyond passenger cars to include trucks, buses, and heavy-duty commercial vehicles. This acquisition expanded SAMIL’s market reach into the commercial vehicle segment, allowing it to cater to a broader range of automotive manufacturers across the globe. 

Q3 Highlights: 

  • Total income for the quarter was ₹27,777 crore, representing an over 8% increase from ₹25,644 crore in the same period last year.  
  • Sequentially, profit rose nearly 4% from ₹949 crore in Q2FY25.  
  • Revenue declined marginally by 1% from ₹28,071 crore in Q2FY25. 
  • Samvardhana Motherson reported a net profit of ₹984.35 crore for Q3FY25, marking a 55.4% year-over-year increase.  

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 25,644.00 27,666.00 78,788 98,692 
Expenses 23,273 24,980 72,537 89,370 
EBITDA 2,370 2,686 6,251.00 9,322.00 
OPM 9% 10% 8% 9% 
Other Income 117 214 70 140 
Net Profit 633.00 984.00 1,670 3,020 
NPM 2.47 3.56 2.12 3.06 
EPS 2.7 13.57 29% 20% 
Hindalco
Hindalco Q3 Results: 60% Profit Surge to ₹3,735 Cr, Revenue at ₹58,899 Cr

Business and Industry Overview: 

Hindalco Industries is the metals flagship company of the Aditya Birla Group, valued at USD 28 billion, and is a leader in the aluminum and copper industries. In April 2020, the company strengthened its position as the world’s largest player in flat-rolled aluminum products by acquiring Aleris Corporation through its subsidiary, Novelis Inc. 

Hindalco operates a state-of-the-art copper facility, which features one of Asia’s largest custom copper smelters. In India, its aluminum operations encompass bauxite mining, alumina refining, copper production, and various downstream processes. The company ranks among the global aluminum majors and has a presence in nine countries. 

The Birla Copper unit is India’s largest private gold producer, manufacturing copper cathodes and various by-products. Hindalco holds Star Trading House status in India, and its aluminum and copper products are recognized on the London Metal Exchange. 

The aluminum industry in India is strategically positioned and is one of the largest producers globally, with clear growth plans and promising prospects for the future. India’s abundant bauxite mineral resources provide a competitive advantage to the industry compared to its global counterparts. As of September 2019, Hindalco’s domestic aluminum capacity was approximately 1.3 million tonnes, which accounted for nearly 40% of India’s total aluminum production. 

Latest Stock News: 

Hindalco Industries has reported a significant increase in its Q3 profits, with a 60% rise, bringing the net profit to Rs 3,735 crore for the December quarter. This is up from Rs 2,331 crore during the same period in the previous financial year (2023-24). The company’s total income also rose, reaching Rs 58,899 crore, compared to Rs 53,088 crore in the previous year.  

In addition to its strong financial performance, Hindalco announced the appointment of Bharat Goenka, currently the CFO-Designate, as the Chief Financial Officer, effective April 1, 2025. 

Due to ongoing geopolitical tensions and President Trump’s tariffs on imports, Satish Pai, Managing Director of Hindalco, said in an interview with Moneycontrol on February 14 that the company expects a neutral to positive impact on its US business. This follows the 25% tariff on all steel and aluminum imports into the United States. 

Segmental information: 

Hindlco has 2 major business segments. 

  1. Aluminum: In the Aluminium Business, Hindalco is a leading integrated producer with both upstream and downstream operations. Upstream operations include bauxite mining, which involves extracting raw materials; alumina refining, where bauxite is processed into alumina; and primary aluminum production, which smelts the alumina into ingots, billets, and wire rods. The downstream products consist of rolled products used in automotive, packaging, construction, and aerospace industries, extrusions for building and transportation, and foils and packaging products, including Freshwrapp and industrial foils. 
  1. Copper: In the Copper Business, Hindalco is India’s largest producer, operating an integrated smelting and refining facility. This segment focuses on producing copper cathodes for wiring and machinery, as well as continuous cast copper rods essential for power transmission. Additionally, valuable by-products such as sulfuric and phosphoric acids are produced for fertilizers and chemicals, along with gold and silver extracted during the smelting process. 

Subsidiary Information:  

  1. Utkal Alumina International Limited 
  1. Minerals & Minerals Limited 
  1. Suvas Holdings Limited. 
  1. Dahej Harbour & Infrastructure Limited 
  1. Hindalco Almex Aerospace Limited 
  1. East Coast Bauxite Mining Company Private Limited 
  1. Renuka Investments & Finance Limited 
  1. Renukeshwar Investments & Finance Limited 
  1. Lucknow Finance Company Limited 
  1. Utkal Alumina Social Welfare Foundation 
  1. Kosala Livelihood and Social Foundation 
  1. Birla Copper Asoj Private Limited 

Q3 Highlights: 

  •  Hindalco Industries reported a significant increase in Q3 profits, with a 60% rise. 
  • Net profit for the December quarter reached Rs 3,735 crore, up from Rs 2,331 crore in the same period of the previous financial year (2023-24). 
  • Total income rose to Rs 58,390 crore, compared to Rs 52,088 crore in the previous year. 
  •  Bharat Goenka, currently the CFO-Designate, has been appointed as the Chief Financial Officer, effective April 1, 2025. 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 52,808.00 58,390.00 223,202 215,962 
Expenses 46,943.00 50,807 200,536 192,090 
EBITDA 5,865.00 7,583 22,666.00 23,872.00 
OPM 11% 13% 10% 11% 
Other Income 281 469 1,307 1,519 
Net Profit 2,331.00 3,735.00 10,097 10,155 
NPM 4.41 6.40  4.70 
EPS 10.37 16.62 44.93 45.19 
Lupin Ltd
Lupin Q3 Results: Profit Soars 39.5% to ₹855 Cr, Revenue Climbs 11%

Business and Industry Overview: 

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, recognised as one of the largest generic pharmaceutical companies globally by revenue. It focuses on areas such as pediatrics, cardiovascular health, anti-infectives, diabetes, asthma, and anti-tuberculosis treatments. The company operates across the entire pharmaceutical value chain, including branded and generic formulations, active pharmaceutical ingredients (APIs), advanced drug delivery systems, and biotechnology products. Lupin’s products reach 70 countries, with a strong presence in advanced markets like the USA, Europe, Japan, and Australia, as well as emerging markets such as India, the Philippines, and South Africa. 

It has a Research Park, located near Pune and Aurangabad, which houses over 1,400 scientists. Lupin’s R&D encompasses the following areas: Generics Research, Process Research, Pharmaceutical Research, Advanced Drug Delivery Systems (ADDS) Research, Intellectual Property Management, Novel Drug Discovery and Development (NDDD), and Biotechnology Research.  

India is the largest global provider of generic drugs and is renowned for its affordable vaccines and generic medications. The Indian pharmaceutical industry is currently ranked third in terms of pharmaceutical production by volume. It has evolved into a thriving sector, growing at a compound annual growth rate (CAGR) of 9.43% over the past nine years. Key segments of the Indian pharmaceutical industry include generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research and manufacturing, biosimilars, and biologics. India boasts the highest number of pharmaceutical manufacturing facilities that meet the standards of the US Food and Drug Administration (USFDA) and has 500 API producers, which account for approximately 8% of the global active pharmaceutical ingredient (API) market. Lupin is a major provider of anti-TB API to several leading global institutions and is among the top five pharmaceutical brands in India, holding a 3.4% market share. 

Latest Stock News: 

Pharmaceutical giant Lupin experienced a surge in its share price on Thursday, February 13, 2025, with shares rising by 5.69% to reach an intraday high of Rs 2,140.20. This increase was driven by a strong performance in the third quarter of the financial year 2025 (Q3FY25). 

Lupin reported a remarkable 39.5% year-on-year increase in profit, which climbed to Rs 855.1 crore, up from Rs 613.1 crore in Q3FY24. Additionally, revenue rose by 11% to Rs 5,767.7 crore, compared to Rs 5,197.4 crore during the same period last year.  

The company’s operational performance was also impressive, with earnings before interest, taxes, depreciation, and amortization (EBITDA) soaring by 30.6% to Rs 1,355.8 crore. This led to an expansion in the EBITDA margin to 23.5%, an increase of 350 basis points from 20% a year ago. 

Segmental information: 

Lupin operates in multiple therapeutic and business segments: 

1. Generics: This segment is a key revenue driver, providing affordable off-patent medications across various therapeutic areas. 

2. Branded Formulations: Lupin has a strong presence in India and emerging markets, with leading brands in cardiovascular health, diabetes, respiratory conditions, gastroenterology, and women’s health. 

3. Speciality Pharmaceuticals: The focus here is on complex and niche therapies, particularly in the fields of neurology and respiratory diseases. 

4. Active Pharmaceutical Ingredients (APIs): Lupin manufactures APIs for both its formulations and for third-party clients around the world. 

5. Biotechnology and Biosimilars: The company is also engaged in the development of biosimilars, especially in oncology and immunology, as part of its long-term growth strategy. 

Subsidiary Information:   

Lupin Limited, a prominent global pharmaceutical company, has established a network of subsidiaries worldwide to enhance its market presence and operational capabilities. Below is an overview of some key subsidiaries: 

1. Lupin Pharmaceuticals, Inc., USA: Serves as Lupin’s U.S. subsidiary, focusing on the development and marketing of generic and branded pharmaceuticals in the American market. 

2. Pharma Dynamics (Proprietary) Ltd., South Africa: A leading generic pharmaceutical company in South Africa, offering a broad range of affordable medications. 

3. Hormosan Pharma GmbH, Germany: Specializes in generic pharmaceuticals, catering to various therapeutic areas within the German healthcare sector. 

4. Multicare Pharmaceuticals Philippines, Inc., Philippines: Focuses on providing high-quality pharmaceutical products to meet the healthcare needs of the Philippines. 

5. Generic Health Pty Ltd., Australia: Engages in the distribution of generic pharmaceutical products across Australia, ensuring accessibility to essential medications. 

6. Nanomi B.V., Netherlands: Involved in advanced drug delivery technologies, contributing to Lupin’s research and development efforts in innovative therapeutics. 

7. Lupin Atlantis Holdings SA, Switzerland: Manages Lupin’s operations and strategic initiatives within the European region. 

8. Lupin Healthcare (UK) Ltd., United Kingdom: Oversees the distribution and marketing of Lupin’s pharmaceutical products in the UK market. 

9. Lupin Pharma Canada Ltd., Canada: Dedicated to the development and commercialization of pharmaceutical products tailored for the Canadian healthcare system. 

10. Lupin Mexico S.A. de C.V., Mexico: Focuses on expanding Lupin’s footprint in the Mexican pharmaceutical market through a range of generic and branded products. 

11. Lupin Life Sciences Limited, India: Established to manage the generics business in India, aligning with Lupin’s strategic focus on the domestic market. 

12. Lupin Manufacturing Solutions Limited: Created to oversee the manufacturing, sale, export, and import of Active Pharmaceutical Ingredients (APIs) and intermediates, as well as to undertake contract development and manufacturing activities. 

Q3 Highlights: 

  • The company achieved a notable 39.5% year-over-year increase in profit, rising to Rs 855.1 crore in Q3 FY24 from Rs 613.1 crore in the same quarter last year.  
  • Revenue grew by 11% year-over-year, reaching Rs 5,767.7 crore compared to Rs 5,197.4 crore in Q3 FY24.  
  • EBITDA surged by 30.6%, climbing to Rs 1,355.8 crore and reflecting a strong operational performance.  
  • The EBITDA margin expanded to 23.5%, marking a 350 basis points increase from the previous year’s margin of 20%. 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 5,197.00 5,768.00 16,642 20,011 
Expenses 4,159.00 4,412 14,921 16,211 
EBITDA 1,038.00 1,356 1,721.00 3,800.00 
OPM 20% 24% 10% 19% 
Other Income 29 54 151 131 
Net Profit 619.00 859.00 448 1,936 
NPM 11.91 14.89 2.69 9.67 
EPS 13.47 18.74 9.45 42.01 
Siemens
Siemens Q3 Results: Net Profit Strong Jumps 22% to ₹614 Crore, Revenue Declines 3%

Business and Industry Overview: 

Siemens Limited is a technology-focused company in India which is a part of Siemens AG, Germany. It specializes in digital and sustainable transformation. The company offers a comprehensive portfolio through Siemens Xcelerator. The Siemens Xcelerator serves as a marketplace where customers can select solutions tailored to their business challenges, including offerings in digital enterprise solutions, industrial cybersecurity, AI/ML, and more. It features a range of technology solutions, such as Digital Enterprise solutions, industrial edge, industrial cybersecurity, IT/OT integration, integrated automation, and Artificial Intelligence (AI) / Machine Learning (ML). Additionally, it offers products like Building X, Electrification X, and Gridscale X, which assist grid, urban, and industrial infrastructure customers on their digital transformation journeys. In the financial year 2024, the company secured orders from various sectors, including renewables and metals, for its cutting-edge technologies. 

With its local expertise and strong global technological leadership, Siemens Limited is well-positioned to support India’s industrial and economic growth through its innovative solutions in electrification, automation, and digitalization. Siemens India has a strong presence across various industries, supported by its robust research and development capabilities, local manufacturing, and efforts in digital transformation. The company aligns strategically with India’s economic policies, including Make in India, the Smart Cities Mission, and Atmanirbhar Bharat, which aim to foster local innovation and enhance infrastructure development. 

Latest Stock News: 

Siemens reported a 22% increase in their consolidated net profit for Q3 FY25, rising to Rs 614.30 crore from Rs 505.40 crore in the same quarter last year. Consolidated revenue from operations fell by 3% to Rs 3,587.20 crore compared to Rs 3,709.50 crore a year ago. Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) declined 11.5% to Rs 401 crore, with a margin contraction from 12.2% to 11.2%. 

CEO Sunil Mathur stated that the revenue had declined due to slower private sector capital expenditure and normalizing demand in digital industries, while emphasizing the growth in Smart Infrastructure and Mobility sectors due to government spending.  

Segmental information: 

Siemens India operates through several key business segments: 

1. Smart Infrastructure: This segment provides solutions for buildings, grid infrastructure, and energy distribution, all aimed at promoting sustainable urban development. 

2. Digital Industries: Focused on automation, digitalisation, and industrial software, this segment optimises manufacturing and process industries. 

3. Mobility: This area offers railway automation, electrification, and rolling stock solutions to enhance India’s transportation and logistics sector. 

4. Energy: Engaged in power generation, transmission, and grid modernisation, this segment supports India’s transition toward cleaner energy sources. 

5. Healthcare (Siemens Healthcare) : This division develops advanced medical imaging, diagnostics, and laboratory automation solutions. 

6. Siemens Financial Services: This segment provides customised financing solutions for industrial and infrastructure projects. 

Subsidiary Information:   

Siemens Rail Automation Private Limited (SRAPL)       

SRAPL, a wholly owned subsidiary of the Company, specializes in the manufacture, supply, design, installation, and commissioning of railway signalling equipment, which includes both trackside and onboard equipment. 

C&S Electric Limited (C&S)       

C&S is a subsidiary of the Company, in which the Company holds a 99.22% equity stake. It is involved in the manufacturing and distribution of low-voltage products and systems, such as switchboards, power distribution products, control products, protection relays, measurement devices, bus duct, and busbar trunking. For the financial year 2023-24, C&S reported a turnover of ₹17,019 million, accounting for 8% of the Company’s consolidated turnover. This represents an increase from ₹15,036 million for the year ended September 30, 2023. Additionally, the Profit from Operations for C&S for the year ended September 30, 2024, was ₹2,497 million, compared to ₹1,544 million in the previous year. 

Siemens Energy India Limited (SEIL)       

SEIL is a wholly owned subsidiary of the Company and was incorporated on February 7, 2024, for the purpose of demerging the Company’s Energy business (as defined in the Scheme) into SEIL. The first financial year for SEIL spans from February 7, 2024, to September 30, 2024. 

Associate Company: Sunsole Renewables Private Limited (Sunsole)       

Sunsole is an associate company of the Company, engaged in the construction, operation, and maintenance of a solar power plant. This plant supplies power generated on a captive basis to the Company. For the year ended September 30, 2024, Sunsole reported a turnover of ₹23 million, compared to ₹24 million for the previous year. Moreover, its profit for the year ended September 30, 2024, was ₹4 million, a significant improvement from a loss of ₹5 million for the year ended September 30, 2023. 

Q3 Highlights: 

  • Siemens’ revenue from operations stood at ₹3,587 crore in Q3 FY25, falling 3.3% from ₹3,710 crore in the same period last year.   
  • The company’s EBITDA contracted to ₹401 crore in the December quarter of FY25. 
  • Net profit is recorded as ₹ 615 crore in Q3 FY25 compared to ₹ 506 crore in the same quarter compared to last year.  

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 3,710.00 3,587.00 19,554 22,240 
Expenses 3,256.00 3,186 17,067 19,136 
EBITDA 453 401.00 2,487.00 3,104.00 
OPM 12% 11% 13% 14% 
Other Income 256 415 496 925 
Net Profit 506.00 615.00 1,962 2,718 
NPM 13.64 17.15 10.03 12.22 
EPS 14.19 17.25 55.06 76.28 
SAIL ltd
SAIL Q3 FY25 Results: 66% Profit Decline Despite 5% Revenue Growth – Stock Rises 3.5%

Business and Industry Overview: 

Steel Authority of India Limited (SAIL) is the largest Indian public sector (government-owned) manufacturing corporation with an annual production capacity of 18.29 million metric tons. While the Indian government holds a major stake of about 65% in SAIL, its Maharatna status allows the company to operate with autonomy in financial and operational matters, enabling faster decision-making and business expansion. The company has a total of 692 patents filed under its name globally, out of which 343 have been granted. More than 64% of the 692 patents are active. SAIL has filed the maximum number of patents in India, followed by Egypt and Germany.

SAIL operates five integrated steel plants, each with a rich legacy and global collaborations. Rourkela Steel Plant (RSP) in Odisha is India’s first public-sector steel plant that was set up with German collaboration. Bhilai Steel Plant (BSP) in Chhattisgarh (1959) and Bokaro Steel Plant (BSL) in Jharkhand (1964) were established with Soviet assistance, and it is India’s first Swadeshi steel plant. Durgapur Steel Plant (DSP) in West Bengal (1965) was set up with British collaboration, while IISCO Steel Plant (ISP) in West Bengal, modernized in 2015 with a ₹16,000 crore investment, houses India’s largest blast furnace. 

SAIL also runs special steel plants like Alloy Steel Plant (ASP) in West Bengal, which supplies the Indian Ordnance Factories; Salem Steel Plant (SSP) in Tamil Nadu for stainless and micro-alloyed steel; and Visvesvaraya Iron & Steel Limited (VISL) in Karnataka for high-quality alloy steels. The Chandrapur Ferro Alloy Plant (CFP) in Maharashtra supports steelmaking with ferro-manganese and silico-manganese. Additionally, SAIL Refractory Units (SRU) in Jharkhand and Chhattisgarh ensure a steady supply of refractory materials. With this vast network, SAIL remains a key pillar of India’s steel industry, catering to infrastructure, transportation, and defence. 

India is the second largest steel manufacturer of crude steel in the world, surpassing Japan in 2019; the industry is growing at a very exponential rate of 5% to 7.3%. And for an emerging economy like India, meeting its hard metal requirement is very important, and the steel sector has been a major contributor to India’s manufacturing output. The iron and steel industry in India is projected to grow from $188.5 billion in 2023 to $264 billion by 2032. This would be a compound annual growth rate (CAGR) of 4.30%. SAIL is India’s largest steel-making company, with integrated plants in the eastern and central regions  

Latest Stock News: 

Steel Authority of India Ltd. (SAIL) reported a 66% decline in net profit for Q3 FY5 despite a 5% increase in revenue. Following the earnings announcement, the stock rose by 3.5%, although it remains 41% below its 52-week high, indicating ongoing challenges in the steel market. 

For Q3 FY25, SAIL’s consolidated net profit stood at ₹141.89 crore, a significant drop from ₹422.92 crore in the same quarter the previous year. This decline was primarily due to higher costs and pricing pressures. Comparatively, profit after tax (PAT) saw an 84% plunge from ₹897 crore in Q2 FY25. 

Revenue from operations grew by 5% year-on-year, reaching ₹24,490 crore, up from ₹23,349 crore. However, on a quarter-on-quarter basis, revenue experienced a slight dip of 0.75% from ₹24,675 crore in Q2 FY25. 

At the operational level, SAIL’s earnings before interest, tax, depreciation, and amortization (EBITDA) declined by 5.3% year-on-year to₹2,029.6 crore, down from₹2,142.5 crore in Q3 FY24. The EBITDA margin contracted to 8.3% in Q3 FY25, compared to 9.2% in the same period last year, reflecting increased input costs and pricing challenges. 

Segmental information

  1. Steel Production:  

These segments position SAIL as an integrated steel producer serving diverse industries like infrastructure, railways, automotive, and defence. It has integrated and special steel plants. This includes: 

  • Flat Steel Products: Hot-rolled (HR) and cold-rolled (CR) coils, sheets, galvanized sheets, and plates used in automobiles, construction, and white goods. 
  • Long Steel Products: Rails, structural steel (joists, channels, angles), TMT bars, and wire rods used in infrastructure and construction. 
  • Specialty Steel Products: Stainless steel, alloy steel, and high-quality special steel catering to defence, railways, and engineering sectors. 

2. Mining & Raw Material Production 

SAIL ensures raw material self-sufficiency through its captive mines for iron ore, coal, limestone, and dolomite, reducing dependency on external suppliers and enhancing cost efficiency. 

3. Ferro Alloys & Refractory Products 

  • Ferro Alloys: Production of ferro-manganese and silico-manganese at Chandrapur Ferro Alloy Plant, essential for steelmaking. 
  • Refractory Products: Manufacturing of refractory bricks and materials through SAIL Refractory Units (SRU) to support high-temperature industrial processes. 

4. Value-Added & Downstream Products 

SAIL focuses on high-margin, value-added products, including: 

  • Galvanized and coated steel for automotive and construction applications. 
  • High-tensile and wear-resistant steel for defence and heavy engineering. 

5. Energy & Power Generation:  

To support its energy-intensive operations, SAIL has captive power plants within its steel plants, ensuring energy security and operational efficiency. These business segments position SAIL as an integrated steel producer, catering to diverse industries, including infrastructure, railways, automotive, defence, and manufacturing. 

Subsidiary Information:

Subsidiaries 

  1. SAIL Refractory Company Limited 
  1. Chhattisgarh Mega Steel Limited 

Associate Company: 

  1. Almora Magnesite Ltd 

Joint Ventures 

  1. NTPC-SAIL Power Company Private Limited 
  1. International Coal Ventures Private Limited 
  1. Bastar Railway Private Limited 
  1. SAIL RITES Bengal Wagon Industry Private Limited 
  1. GEDCOL SAIL Power Corporation Limited 
  1. Mjunction Services Limited 
  1. Bokaro Power Supply Company Private Limited 
  1. Bhilai Jaypee Cement Limited 
  1. SAIL Kobe Iron India Private Limited 
  1. SAIL Bansal Service Centre Limited 
  1. Prime Gold-SAIL JVC Limited 
  1. SAIL SCL Kerala Limited  
  1. VSL SAIL JVC 
  1. Romelt SAIL (India) Limited 

Q3 Highlights

  • SAIL’s net profit dropped 66% in Q3 FY25 despite 5% revenue growth. 
  • The stock rose 3.5% post-earnings but is 41% below its 52-week high. 
  • Q3 FY25 net profit is ₹141.89 crore, down from ₹422.92 crore in Q3 FY24. 
  • PAT fell 84% from ₹897 crore in Q2 FY25. 
  • Revenue is ₹23,349  crore, up 5% YoY but down 0.75% QoQ. 

Financial Summary

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 23,349.00 24,490.00 104,448 105,378 
Expenses 21,206.00 22,460 96,410 94,229 
EBITDA 2,142 2,030.00 8,038.00 11,149.00 
OPM 9% 8% 8% 11% 
Other Income 355 393 1,856 665 
Net Profit 423.00 142.00 2,177 3,067 
NPM 1.81 0.58 2.08 2.91 
EPS 1.02 0.34 5.27 7.42 
Muthoot Finance Ltd.
Muthoot Finance Q3 Results: Net Profit Surges 22% to ₹1,392 Crore and Growth & Market Insights

Business and Industry Overview: 

Muthoot Finance Limited is India’s largest gold loan non-banking financial corporation. It offers services like financing gold loans, insurance, housing loans, SME loans, and money transfer services. It is a gold financing company that provides loans against gold jewellery as collateral. The company is headquartered in Kochi, Kerala, and has over 5000 branches throughout the country. Outside India, Muthoot Finance is established in the UK, the US, and the United Arab Emirates. The company falls under the brand umbrella of the Muthoot Group. Its stocks have been listed on the BSE and NSE since its initial public offering in 2011. The target market of Muthoot Finance includes small businesses, vendors, farmers, traders, SME business owners, and salaried individuals.

Non-Banking Financial Companies (NBFCs) have witnessed significant growth in India’s financial ecosystem, playing a crucial role in credit expansion and financial inclusion. Their market share in credit distribution increased from 12% in 2008 to 18% in 2019, before slightly declining to 16% in 2022 due to increased competition from banks. Muthoot Finance is a leader in the microfinance landscape in India.  

Latest Stock News: 

Muthoot Finance reported a net profit of ₹1,363 crore for the third quarter of FY25, reflecting a growth of 32.7% compared to ₹1,027.3 crore during the same period last year. Following the announcement of these strong Q3 results, Muthoot Finance’s share price surged over 5% in early trading on 13 February 2025. The shares rallied by as much as 6.45%, reaching a fresh 52-week high of ₹2,321.80 on the BSE. 

The company’s significant net profit growth was driven by robust loan growth and margin expansion. Additionally, Muthoot Finance reported its highest-ever consolidated loan assets under management (AUM) at ₹1.11 lakh crore as of December 31, 2024. During the quarter, the consolidated loan AUM increased by ₹7,159 crore, representing a 7% quarter-on-quarter growth. 

Segmental information

  • Gold loans: It offers gold loans at low interest rates to its customers. 
  • Housing finance: It offers housing finance options to its customers.  
  • Personal loans: It offers personal loans. 
  • Wealth management: It offers wealth management solutions. 
  • Money transfer: It offers money transfer services. 
  • Insurance broking: It offers insurance broking services. 
  • Microfinance: It offers microfinance services. 

Subsidiary Information:

Muthoot Money Ltd. (MML) became a wholly owned subsidiary of Muthoot Finance Ltd. in October 2018. MML is a Reserve Bank of India (RBI) registered Non-Banking Finance Company primarily engaged in providing gold loans. 

Muthoot India Brokers Pvt Ltd (MIBPL) also became a wholly owned subsidiary of Muthoot Finance Ltd in September 2016. MIBPL is an unlisted private limited company that has held a Direct Broker license from the Insurance Regulatory and Development Authority (IRDA) since 2013. 

Asia Asset Finance PLC (AAF) in Colombo, Sri Lanka, became a foreign subsidiary of Muthoot Finance on December 31, 2014. As of December 31, 2024, Muthoot Finance holds 91 million equity shares in AAF, representing 72.92% of the company’s total capital. The loan portfolio stands at LKR 28,404 million as of December 31, 2024. 

Muthoot Homefin (India) Limited is a Housing Finance Company registered with the National Housing Bank (NHB). It became a wholly owned subsidiary of Muthoot Finance Ltd. in August 2017.  

Q3 Highlights

  • Muthoot Finance reported a 32.7% YoY increase in Q3 FY25 net profit to ₹1,363 crore. 
  • Following the results, the stock surged over 5%, reaching a 52-week high of ₹2,321.80. 
  • The company’s loan AUM hit ₹1.11 lakh crore, its highest-ever level. 
  • The loan AUM grew by ₹7,159 crore (7% QoQ) in Q3 FY25. 

Financial Summary:  

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 3,168.00 4,423.00 10,515 12,635 
Expenses 566.00 913 2,110 2,513 
EBITDA 1,390 1,863.00 4,696.00 5,455.00 
OPM 44% 42% 45% 45% 
Other Income 8 8 29 59 
Net Profit 1,027.00 1,363.00 3,474 3,474 
NPM 32.42 30.82 33.04 27.50 
EPS 25.59 33.95 86.52 100.87 
Tata Investment Corporation ltd
Tata Investment Corporation Q3 Results: Net Income Falls to ₹196.1 Million, Profit Declined

Business and Industry Overview: 

The Tata Investment Corporation Limited (TICL) is a non-banking financial company (NBFC) which is mainly engaged in long-term investments in various industries. East known as India’s Investment Corporation, the company invests in equity shares, loan equipment and equity-related securities, both listed and unlisted. The TICL was promoted by Tata Sons Private. Limited in 1937 and a closely held unit until 1959 remained one of the publicly listed investment companies on the Bombay Stock Exchange. Initially focused on supporting new enterprises, the TICL gradually turned into an investment company with a diverse portfolio. For decades, it has played an important role in the development of many famous Indian companies including SKF Bairing (India) Limited, Ceat Ltd., and National Ryan Corporation. The TICL is currently a subsidiary of Tata Sons, with other TATA companies, 73.38% of its paid capital. The company’s leadership of Noel Tata and F.N. As Vice Chairman is supported by a team of subdaras, financial and investment experts. Non-Banking Financial Companies (NBFCs) have seen significant growth in India’s financial ecosystem, which play an important role in credit expansion and financial inclusion. Their market share in credit distribution increased from 12% in 2008 to 18% in 2019, before 2022 increased competition from banks to 16%. And TICL is one of the famous NBFCs, which has played an important, important role in financing new businesses. 

Latest Stock News: 

The Tata Investment Corporation Limited (TICL) recorded a sharp decline in financial performance for the Q3 FY25, with the revenue fell from ₹ 43.76 million to ₹ 31.68 million a year ago. Per share (EPS) per share from ₹ 10.52 to ₹ 3.88 per share. For nine months, the revenue decreased from ₹ 3,284.9 million to ₹ 2,896.1 million, while net income fell from ₹ 2,743.7 million to ₹ 3,244.9 million, decreased from ₹ 64.13 to ₹ 54.23 with EPS to ₹ 64.13 to ₹ 54.23 with EPS. , Which indicates recession in earnings and revenue. 

Segmental information: 

Equity Investment: TICL mainly invests in a diverse portfolio of equity shares and securities of companies listed and unlisted in various industries including TATA group companies.  

Loans and definite-income investment: The company also invests in loan equipment, including bonds and other certain-oriented securities, providing a stable stream of interest income.  

Dividend and interest income: A important part of TICL’s revenue comes from dividends and interest earned on its investment, ensuring stable returns over time.  

Asset Management: TICL is a co-consent of Tata Asset Management Private Limited, who manages mutual funds and investment portfolio for institutional and retail investors. 

Subsidiary Investments: 

  1. Simto Investment Company Limited (Assistant) – TICL increased its investment portfolio by Simto Investment Company Ltd. It has a majority stake in. 
  1. Tata Asset Management Private Limited (Associate Company)-TICL is a co-commotor of Tata Asset Management, which manages Tata Mutual Fund and provides investment management services.  
  1. Tata Trustee Company Private Limited (Associate Company) – This unit oversees the Tata Mutual Fund schemes, which ensure governance and compliance in property management.  
  1. AMALGAMATED Plantation Private Limited (Associate Company) – TICL has an investment in tea plantation company, the largest in India, which supports its diverse portfolio. 

Q3 Highlights: 

  • Revenue is recorded as ₹38 million, down from ₹516.2 million in Q3 FY24. 
  • Net income is reported as ₹196.1 million, down from ₹532.4 million a year ago. 
  • EPS is ₹3.88, compared to ₹10.52 in the previous year. 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 31.68 43.76 277 325 
Expenses 6.29 9 32 33 
EBITDA 25.39 34.76 245.00 292.00 
OPM 87% -19% 88% 91% 
Other Income 17 26 36 65 
Net Profit 24.08 34.33 252 284 
NPM 76.01 78.45 90.97 87.27 
EPS 10.52 3.88 49.78 76.09